Websites, domains, hosts that links to regeneron.com
Our database shows, that the website regeneron.com is linked by a total of 18 websites.
Number of websites/domains displayed: 18
Results found: 18
Websites discovered:
Official EYLEA® (aflibercept) Injection Websitehttp://pageoverview.com/website-report/eylea.us
EYLEA is an FDA-approved medication that’s administered by an injection into the eye to treat certain retina diseases. See safety and risk information.
- Expected expiration: September 10th in 2020
- Creation date: September 11th in 2008
- Renew date: January 1st in 2018
Home - MedTechhttp://pageoverview.com/website-report/medtech.org
MedTech
- Expected expiration: December 12th in 2019
- Creation date: December 12th in 2003
- Renew date: March 8th in 2015
- Google Analytics: 51162142-1
- AddThis User: medtechassoc
Class EurActivhttp://pageoverview.com/website-report/euractiv.it
Informazione indipendente e specializzata sugli affari della Unione Europea. Il portale italiano del network editoriale EurActiv con notizie, interviste, articoli e approfondimenti sulle politiche dell'Italia e dell'Europa.
- Expected expiration: March 5th in 2018
- Creation date: August 4th in 2005
- Renew date: March 21st in 2017
- Google Analytics: 3292745-6
- Google Plus Account: 107602884913792745742
DUPIXENT® (dupilumab) HCP Websitehttp://pageoverview.com/website-report/dupixenthcp.com
DUPIXENT® is for your adult patients with uncontrolled moderate-to-severe atopic dermatitis. Learn more now. Please see Prescribing Information and Important Safety Information on website.
- Expected expiration: October 13th in 2018
- Creation date: October 13th in 2016
- Renew date: October 13th in 2016
National Forumhttp://pageoverview.com/website-report/hearthealthystrokefree.org
- Expected expiration: January 24th in 2019
- Creation date: January 24th in 2007
- Renew date: November 25th in 2017
- Google Analytics: 65002064-1
velocigene.comhttp://pageoverview.com/website-report/velocigene.com
- Expected expiration: November 20th in 2022
- Creation date: November 20th in 2000
- Renew date: October 11th in 2017
TAGC Home Pagehttp://pageoverview.com/website-report/genetics2016.org
- Expected expiration: October 24th in 2017
- Creation date: October 24th in 2012
- Renew date: December 21st in 2015
- Google Analytics: 59728600-1
- Google Plus Account: 106737238985338171845
Regeneron Pharmaceuticals | Delivering life-transforming medicineshttp://pageoverview.com/website-report/regeneron.com
Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need.
- Expected expiration: July 9th in 2023
- Creation date: July 10th in 1997
- Renew date: February 20th in 2017
- Google Analytics: 4731979-2
Senior transportation, helping seniors keep their independence | ITNAmericahttp://pageoverview.com/website-report/itnamerica.org
Non-profit solution to senior transportation and people with visual impairments. The ITN is a sustainable, community-based transportation service for seniors.
- Expected expiration: October 5th in 2018
- Creation date: October 5th in 2001
- Renew date: October 6th in 2016
- Google Analytics: 4084855-1
- Google Plus Account: 112936364686166303389
PRALUENT® (alirocumab) for Health Care Professionalshttp://pageoverview.com/website-report/praluenthcp.com
Find Health Care Professional focused information about PRALUENT® (alirocumab), for patients with poorly controlled LDL-C and HeFH or clinical ASCVD.
- Expected expiration: June 4th in 2018
- Creation date: June 4th in 2015
- Renew date: May 31st in 2017
High LDL Cholesterol | Take Down Cholesterolhttp://pageoverview.com/website-report/takedowncholesterol.com
Learn about high LDL cholesterol and watch a documentary sharing true stories of those living with the condition.
- Expected expiration: October 9th in 2018
- Creation date: October 9th in 2014
- Renew date: October 5th in 2016
IL-6 and Rheumatoid Arthritis | Think About the Jointshttp://pageoverview.com/website-report/raandil6.com
Elevated IL-6 plays an important role in RA. Learn about articular and systemic effects of persistently elevated IL-6 levels in RA patients.
- Expected expiration: July 13th in 2019
- Creation date: July 13th in 2015
- Renew date: July 9th in 2017
PRALUENT® (alirocumab) Injection | Official Sitehttp://pageoverview.com/website-report/praluent.com
Discover PRALUENT® (alirocumab) for adults with uncontrolled bad cholesterol who have heart problems due to plaque build-up in arteries or HeFH.
- Expected expiration: April 25th in 2018
- Creation date: April 25th in 2014
- Renew date: April 21st in 2016
DUPIXENT® (dupilumab) Now Availablehttp://pageoverview.com/website-report/dupixent.com
Learn about DUPIXENT®, a new treatment for adults with uncontrolled moderate-to-severe eczema (atopic dermatitis). See Important Safety Information, indication and patient information.
- Expected expiration: May 29th in 2018
- Creation date: May 29th in 2015
- Renew date: May 25th in 2017